drug
Viral Diseases
Preclinicalupdated 3mo agoby Max Biopharma Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 7mo ago
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that